MR
Mereo BioPharma
MREO.L·LSELondon UKFounded 201530 employees
Micro CapbiotechPublicRare DiseaseMusculoskeletal
Platform: Setrusumab OI
Market Cap
$0.08B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (MREO.L)
Loading MREO.L stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| MRE-2348 | MRE-2348 | Preclinical | 2 | FXIa | Heart FailurePompe | ||
| MRE-7592 | MRE-7592 | Phase 1/2 | 1 | JAK1 | ObesityALL |
SEC Filings & Financial Documents
SEC filings are not available for LSE-listed companies.
Mereo BioPharma trades on LSE (GB). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)